Literature DB >> 31812157

Surgical niche for the treatment of erectile dysfunction.

Cheng-Hsing Hsieh1,2, Geng-Long Hsu3, Shang-Jen Chang1,2, Stephen Shei-Dei Yang1,2, Shih-Ping Liu4,5, Ju-Ton Hsieh4,5.   

Abstract

Penile erection implicates arterial inflow, sinusoidal relaxation and corporoveno-occlusive function. By far the most widely recognized vascular etiologies responsible for organic erectile dysfunction can be divided into arterial insufficiency, corporoveno-occlusive dysfunction or mixed type, with corporoveno-occlusive dysfunction representing the most common finding. In arteriogenic erectile dysfunction, corpora cavernosa show lower oxygen tension, leading to a diminished volume of cavernosal smooth muscle and consequential corporoveno-occlusive dysfunction. Current studies support the contention that corporoveno-occlusive dysfunction is an effect rather than the cause of erectile dysfunction. Surgical interventions have consisted primarily of penile revascularization surgery for arterial insufficiency and penile venous surgery for corporoveno-occlusive dysfunction, whatever the mechanism. However, the surgical effectiveness remained debatable and unproven, mostly owing to the lack of consistent hemodynamic assessment, standardized select patient and validated outcome measures, as well as various surgical procedures. Penile vascular surgery has been disclaimed to be the treatment of choice based on the currently available guidelines. However, reports on penile revascularization surgery support its utility in treating arterial insufficiency in otherwise healthy patients aged <55 years with erectile dysfunction of late attributable to arterial occlusive disease. Furthermore, it is noteworthy that penile venous surgery might be beneficial for selected patients with corporoveno-occlusive dysfunction, especially with a better understanding of the innovated venous anatomy of the penis. Penile vascular surgery might remain a viable alternative for the treatment of erectile dysfunction, and could have found its niche in the possibility of obtaining spontaneous, unaided and natural erection.
© 2019 The Japanese Urological Association.

Entities:  

Keywords:  arterial insufficiency; erectile dysfunction; penile revascularization; veno-occlusive dysfunction; venous stripping

Mesh:

Year:  2019        PMID: 31812157     DOI: 10.1111/iju.14157

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Male Sexual Dysfunction.

Authors:  Danyon Anderson; John Laforge; Maggie M Ross; Robert Vanlangendonck; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

Review 2.  The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016-2021).

Authors:  Mohammed Monirul Islam; Nimbagal Raghavendra Naveen; Posina Anitha; Prakash S Goudanavar; G S N Koteswara Rao; Santosh Fattepur; Muhammad Muhitur Rahman; Predeepkumar Narayanappa Shiroorkar; Mohammed Habeebuddin; Girish Meravanige; Mallikarjun Telsang; Sreeharsha Nagaraja; Syed Mohammed Basheeruddin Asdaq; M D Khalid Anwer
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

3.  Penile implant surgery for conservative therapy resistant erectile dysfunction in a 19y-old.

Authors:  Filip Weckx; Koenraad Van Renterghem
Journal:  Urol Case Rep       Date:  2020-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.